11 – 17 October 2021, we need your help! 76% of primary bone cancer patients in the UK are misdiagnosed and 14% of cases are in the skull, face and jaw. During #BoneCancerAwareness Week we’re educating dentists, dental healthcare professionals,…
News
John Gross, M.D., M.S. This website is intended to promote education in bone and soft tissue pathology. Cases are presented in the format of radiologic images paired with scanned microscopic slides for the case. New cases will be uploaded every 8…
Bone Cancer Awareness Week 2021 11 – 17 October 2021, we need your help! 76% of primary bone cancer patients in the UK are misdiagnosed and 14% of cases are in the skull, face and jaw. During #BoneCancerAwareness Week we’re educating dentists,…
Sep. 17, 2021TOPIC: Patients & Members, Advocacy, Patient Stories, Voices of Rare Cancer A Message to Chondrosarcoma Patients: Shayna’s Rare Cancer StoryPosted by Rohan Narayanan Shayna had advanced metastatic chondrosarcoma, and her…
Get Involved, Spread the Word & Hear Stories From Those Impacted …
Virtual Dialogue 3: Taking Charge of Your Care
Third International Virtual Dialogue The Chondrosarcoma CS Foundation, Inc. held the Third International Forum / Virtual Dialogue featuring a panel of Chondrosarcoma survivors and prominent experts to…
Rare Disease Innovation and Data Sharing Accelerated by New RDCA-DAP Program TUCSON, Ariz. and WASHINGTON, September 15, 2021 — The Rare Disease Cures Accelerator-Data and Analytics Platform initiative (RDCA-DAP ®) officially launched its next…
Study Description
Go to Brief Summary:
This phase II trial studies how well atezolizumab works in treating patients with chondrosarcoma or clear cell sarcoma that is newly diagnosed, cannot be removed by surgery (unresectable), or has spread to…